Anecortave Acetate 15 mg

DRUG2 trials

Sponsors

Manhattan Eye, Ear & Throat Hospital, Alcon Research

Conditions

AMDMaculopathy, Age-Related

Phase 1

Study of the Combination of Anecortave Acetate and Triamcinolone Acetonide for the Treatment of Exudative Age-Related Macular Degeneration (AMD)

CompletedNCT00211419

Manhattan Eye, Ear & Throat HospitalMaculopathy, Age-Related

Updated: 2012-10-24

Phase 2

A Phase II Study of Anecortave Acetate for the Treatment of Exudative Age-Related Macular Degeneration

CompletedNCT00346957

Alcon ResearchAMD

Start: 1999-04-30End: 2003-04-30Updated: 2012-03-06